Figure 1: Hepatocellular carcinomas (HCC) diversify during tumour evolution, leading to multiple co-existing subtypes in a significant proportion of HCC that will require combination systemic therapies to treat the disease. (IMAGE)
Caption
Figure 1: Hepatocellular carcinomas (HCC) diversify during tumour evolution, leading to multiple co-existing subtypes in a significant proportion of HCC that will require combination systemic therapies to treat the disease.
Credit
Credit: A*STAR’s Genome Institute of Singapore
Usage Restrictions
Credit: A*STAR’s Genome Institute of Singapore
License
Original content